Yes, very much so – LMT and now distributing Osteomesh and plug,...

Yes, very much so – LMT and now distributing Osteomesh and plug, they have also published on their website: https://lmtsurgical.com/products/biologics/ and revenue is already flowing in.

The recent investor deck had a nice roadmap slide on phase 2 and phase 3- just rehashing here for anyone that missed it.

Phase two - expanding application scope to new areas such as dental and orthopaedic, specifically long bone and spine. Note that we already announced research collab with Queensland UNI for regrowth of Long Bone defects and had encouraging early stage results in patients who have lost more than 6 centimeters of bone.

Also note Osteopore has developed bioresorbable 3D-printed dental plug which promotes bone growth in the jaw, reducing the likelihood of bone shrinkage after tooth extraction. Currently, patients requiring dental implants have to wait 3-6 months for bone to grow in the tooth socket after extraction. Osteopore aims to deliver a shorter, reliable and less painful treatment process as the plugs are placed immediately after extraction, eliminating the need for bone grafts. This is still in clinical trials.

And additionally, they conducted the first in human trials using the Osteopore scaffold in a range of orthopaedic procedures, where significant lengths of long bones have been damaged. The Osteopore scaffold has recently demonstrated significant clinical success in tibia regenerations in Australia & Singapore. This product is still in clinical trials too.

Then consider phase 3 for new polymers and 3D printed scaffolds for regeneration of other tissues.

Also another ace up the sleeve - they previously announced it had successfully completed multiple animal trials for a number of different surgical applications which could possibly translate into products for the veterinarian market.

Our YoY growth will get market attention soon enough. Patience